Callisto Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Callisto Inc. - overview

Established

2022

Location

Tokyo, Tokyo, Japan

Primary Industry

Healthcare IT

About

Based in Tokyo, Japan, and founded in 2022, Callisto Inc operates as a health technology company that uses artificial intelligence and manufactures pharmaceuticals and medical equipment. In April 2023, Callisto Inc. raised JPY 200 million in seed funding led by ITOCHU Technology Ventures and NOW (Japan). As of 2023, the company is led by its CEO Han Chang-hee.


The company offers a technology-based platform that compiles medical picture data for the research and development of healthcare Artificial Intelligence. Additionally, the company develops Artificial Intelligence solutions for manufacturers of pharmaceuticals and medical equipment. The platform offers data set copyrights and the artificial intelligence data offered by the firm could be used by pharmaceutical companies, medical device manufacturers, AI companies, etc. It also pays the authors for their data usage.


The company plans to use the April 2023 funding to develop custom drug discovery using Artificial Intelligence, as well as a data platform for healthcare.


Current Investors

ITOCHU Technology Ventures, NOW

Primary Industry

Healthcare IT

Sub Industries

Healthcare IT, Medical Software

Website

www.callisto-ai.com

Verticals

Artificial Intelligence

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.